Skip to main content
Eligibility
for people ages 18 years and up
Location
at San Francisco, California and other locations
Dates
study started
estimated completion:
Principal Investigator

Description

Summary

This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP-690,550.

Official Title

A Multi-Center, Open-Label Study Of CP-690,550 In Subjects With Moderate To Severe Ulcerative Colitis

Keywords

Ulcerative Colitis open-label long term treatment Tofacitinib

Eligibility

You can join if…

Open to people ages 18 years and up

  • Subjects who completed induction studies A3921094 or A3921095 and were classified as not meeting clinical response criteria; OR
  • Subjects who completed maintenance study A3921096 or who discontinued treatment early in Study A3921096 due to treatment failure.

You CAN'T join if...

  • Subjects who had a major protocol violation in Study A3921094, A3921095 or A3921096.
  • Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.
  • Subjects who have had surgery for ulcerative colitis or in the opinion of the investigator, are likely to require surgery for ulcerative colitis during the study period.

Locations

  • Cedars Sinai Medical Center - Department of Pathology and Lab Medicine accepting new patients
    Los Angeles, California, 90048, United States
  • Cedars Sinai Medical Center -Thalians Bldg. accepting new patients
    Los Angeles, California, 90048, United States
  • Cedars Sinai Medical Center accepting new patients
    Los Angeles, California, 90048, United States
  • Cedars Sinai Surgery Center accepting new patients
    Los Angeles, California, 90048, United States
  • Cedars-Sinai Medical Center Inflammatory Bowel Disease Center accepting new patients
    Los Angeles, California, 90048, United States
  • Alliance Clinical Research terminated
    Oceanside, California, 92056, United States
  • Center for Endoscopy- Covenant Surgical Partners terminated
    Oceanside, California, 92056, United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Pfizer
Links
To obtain contact information for a study center near you, click here.
ID
NCT01470612
Phase
Phase 3
Lead Scientist
Fernando Velayos
Study Type
Interventional
Last Updated
May 1, 2017
I'm interested in this study!